BASClinical Trials•globenewswire•August 14, 2025 at 05:15 AM

Basilea announces in-licensing of a novel clinical phase 3-ready oral antibiotic

Sentiment:Positive (70)

Ad hoc announcement pursuant to Art. 53 LR

Read the full article from the original source for complete details and context.

Article published on August 14, 2025 by globenewswire